MedTrace Logo

Changes in Body Composition With Patients Under Androgen Deprivation Therapy

NCT04037488 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2019-07-30

No results posted yet for this study

Summary

This study aimed to evaluate the correlation of change in body composition and oncological outcomes of prostate cancer patients under androgen deprivation therapy(ADT).

Conditions

Interventions

DIAGNOSTIC_TEST

Inbody 320

Total Skeletal muscle mass (SMM), Skeletal muscle index (SMI), Relative Skeletal muscle mass index (RASM), Fat body mass (FBM), Body mass index (BMI), Body fat percentage, Body water content, Edema Value were calculated by Inbody 320

Sponsors & Collaborators

  • HanAll BioPharma Co., Ltd.

    collaborator INDUSTRY

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chang Wook Jeong, MD. PHD. · Seoul National University Hospital

Eligibility

Min Age
20 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-31
Primary Completion
2021-10-30
Completion
2021-10-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04037488 on ClinicalTrials.gov